Airain Ltd’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Airain Ltd’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$292K	Buy	29,901 +18,301	+158%	+$374K	0.01%	667
2017 Q1	$281K	Buy	+11,600	New	+$290K	0.01%	636
2015 Q2	–	Sell	-1,748	Closed	-$163K	–	1215
2015 Q1	$163K	Buy	+1,748	New	+$149K	0.01%	731
2013 Q3	–	Sell	-4,950	Closed	-$262K	–	739
2013 Q2	$262K	Buy	+4,950	New	+$217K	0.04%	413

Other funds holding MACK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Airain Ltd's MACK Position: Q2 2017 in Review

Airain Ltd increased its Merrimack Pharmaceuticals, Inc. (MACK) stake by 158% in Q2 2017, buying an estimated $374K and bringing the position to 29,901 shares worth $292K. The position accounts for 0.01% of the portfolio, ranked #667.

Airain Ltd first reported a position in MACK in Q2 2013 and has held it in 4 quarters since. 119 funds tracked by Wall St. Rank hold MACK as of Q2 2017.

Airain Ltd held 29,901 shares of Merrimack Pharmaceuticals, Inc. worth $292K as of Q2 2017.
Airain Ltd bought 18,301 Merrimack Pharmaceuticals, Inc. shares in Q2 2017, an estimated $374K.
Merrimack Pharmaceuticals, Inc. made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #667 holding.
Airain Ltd first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and has held it in 4 quarters since.
119 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.